Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Royalty Pharma plc is one of them. Royalty Pharma plc (NASDAQ:RPRX), a leader in biopharma royalties, made major strategic moves in September 2025. The company completed a $2 billion senior notes offering maturing in 2031, 2035, and 2055, enhancing its ability to acquire long-duration royalty assets, fund deals, and strengthen its capital structure. The firm continues to benefit from growing adoption ...